Dr. Reddy’s Laboratories Ltd has announced that its promoters have transferred 17.17 crore equity shares, representing 20.58 percent of the company’s equity, to family trusts through an off-market transaction on September 17, 2025.
The company said the transfer is part of a private family arrangement aimed at facilitating succession planning and streamlining family assets. The company clarified that there has been no change in the overall promoter shareholding, which remains at 22.23 crore shares or 26.64 percent of the company’s equity.
As part of the transaction, Satish Reddy Kallam transferred 7.56 crore shares (9.06%) to VSD Family Trust, reducing his personal holding to 1.01 crore shares (1.21%). G V Prasad transferred 9.61 crore shares (11.51%) to GVP Family Trust, bringing down his individual holding to zero.
| Category | Before Acquisition | After Acquisition |
|---|---|---|
| VSD Family Trust | 0 | 7,56,30,620 |
| GVP Family Trust | 0 | 9,60,95,920 |
| Satish Reddy Kallam | 8,57,38,125 | 1,01,07,505 |
| G.V. Prasad | 9,60,95,920 | 0 |
| Total Shares with PACs | 22,23,05,640 | 22,23,05,640 |
| % of total share capital | 26.64% | 26.64% |
Dr. Reddy’s equity shares are listed on BSE and NSE, while its ADRs are listed on NSE(IFSC) and NYSE. The total equity share capital remains unchanged at 83.46 crore shares of face value Rs 1 each.
Shares of Dr. Reddy’s Laboratories were trading at Rs 1,320.50 on Friday, down 0.17 percent within a day’s range of Rs 1,312-1,326.80. The stock has gained 1.57 percent over the past year, trading between Rs 1,020 and Rs 1,405.90 during the period.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
